Home › Core › ISCC-IDs › 28CrWh7FFdRMT

View ISCC-ID

Core Data

28CrWh7FFdRMT
ISCC-ID - digital asset identifier
CCjCyp5bh2PNF-CTFWkBxLqXU9m-CDLexB96dcaQp-CR8UA2SquzScn
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

neoadjuvant pf05280014 a potential trastuzumab biosimilar versus trastuzumab for operable her2+ breast cancer

Ledger Reference

coblo
Source Ledger/Blockchain
554037
N-th ISCC Decleration on source ledger
3937eb141e4f0ba677dbf25ec82325c0a688bcfb2afa059d46c648a20703b875
Hash of block that includes the ISCC-DECLARATION
5d766a583ae8cc07a9629dc0e885593487f37da78aa3d50f43e8a95d64b66998
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Neoadjuvant PF-05280014 (a potential trastuzumab biosimilar) versus trastuzumab for operable HER2+ breast cancer", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Philip E. Lammers", "@type": "Person"}, {"name": "Magdolna Dank", "@type": "Person"}, {"name": "Riccardo Masetti", "@type": "Person"}, {"name": "Richat Abbas", "@type": "Person"}, {"name": "Fiona Hilton", "@type": "Person"}, {"name": "Jennifer Coppola", "@type": "Person"}, {"name": "Ira Jacobs", "@type": "Person"}], "license": "cc-by", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://www.nature.com/articles/s41416-018-0147-1.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "Springer Nature", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1038/s41416-018-0147-1", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCjCyp5bh2PNF-CTFWkBxLqXU9m-CDLexB96dcaQp-CR8UA2SquzScn", "propertyID": "ISCC"}], "datePublished": "2018-07-13"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close